Signaling Pathways - Farnesoid X receptors (FXRs) - c-Kit - sodium channel - Animal Experiments
清除全部
- B5954 Dasatinib Monohydrate中文名: 达沙替尼一水合物Target: PDGFR|c-Kit|Bcr-Abl|SrcSummary: ABL\SRC\KIT\PDGFR以及其它酪氨酸激酶抑制剂
- B5953 Dovitinib (TKI258) LactateTarget: CSF-1R|FLT3|VEGFR|PDGFR|c-Kit|FGFRSummary: 酪氨酸激酶抑制剂(TKI)
- B5854 Pexidartinib (PLX3397)3 Citation中文名: 培西达替尼Target: FLT3|c-Kit|CSF1RSummary: CSF-1R抑制剂
- B5835 AZD2932Target: FLT3|VEGFR|PDGFR|c-KitSummary: VEGFR-2\PDGFRβ\Flt-3和c-Kit的抑制剂
- B4888 Obeticholic Acid2 Citation中文名: 奥贝胆酸Target: Farnesoid X receptors (FXRs)Summary: FXR激动剂
- B2278 Ibutilide Fumarate中文名: 富马酸伊布利特Target: Voltage-gated Potassium (KV) Channels|Voltage-gated Calcium Channels (CaV)|sodium channelSummary: III类抗心律失常药物
- B2249 Lamotrigine1 Citation中文名: 拉莫三嗪Target: 5-HT receptors|sodium channelSummary: 5-HT抑制剂,钠通道阻断剂
- B1528 XL335Target: Farnesoid X receptors (FXRs)Summary: FXR激动剂
- B2171 Imatinib (STI571)中文名: 伊马替尼Target: PDGFR|c-Kit|Bcr-AblSummary: 蛋白酪氨酸激酶抑制剂
- A8550 Telatinib (BAY 57-9352)中文名: 替拉替尼Target: VEGFR|PDGFR|c-KitSummary: VEGFR-2/-3、PDGFR-β和c-Kit抑制剂